Ligands for the murine NKG2D receptor: expression by tumor cells and activation of NK cells and macrophages
The DOI matches its Crossref record; 41 of the 41 references it cites were found in a registry or an index.
Abstract
Natural killer (NK) cells attack tumor and infected cells, but the receptors and ligands that stimulate them are poorly understood. Here we report the expression cloning of two murine ligands for the lectin-like receptor NKG2D. The two ligands, H-60 and Rae1 beta, are distant relatives of major histocompatibility complex class I molecules. NKG2D ligands are not expressed by most normal cells but are up-regulated on numerous tumor cells. We show that mouse NKG2D is expressed by NK cells, activated CD8+ T cells and activated macrophages. Expression of either NKG2D ligand by target cells triggers NK cell cytotoxicity and interferon-gamma secretion by NK cells, as well as nitric oxide release and tumor necrosis factor alpha transcription by macrophages. Thus, through their interaction with NKG2D, H-60 and Rae1 beta are newly identified potent stimulators of innate immunity.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Previous studies from our laboratory demonstrated that transplanted tumor cells expressing NKG2D ligands are rejected by NK cells and, in some cases, T cells (Diefenbach et al., 2000, 2001, 2003)”
From p53-dependent chemokine production by senescent tumor cells supports NKG2D-dependent tumor elimination by natural killer cells (2013) · cites this paper as Diefenbach et al., 2000
Citations
Cites
Selective extraction of polyoma DNA from infected mouse cell cultures
Hirt, B. (1967) · Journal of Molecular Biology · doi:10.1016/0022-2836(67)90307-5 · Cited by 5,146 · cited 1×
“The extrachromosomal DNA was extracted from the sorted cells as describe”
MethodPhenotypic Analysis of Antigen-Specific T Lymphocytes
Altman, J. D., Moss, P. A. H., Goulder, P. J. R., Barouch, D. H., McHeyzer-Williams, M. G., Bell, J. I., McMichael, A. J., & Davis, M. M. (1996) · Science · doi:10.1126/science.274.5284.94 · Cited by 3,544 · cited 1×
“The recombinant protein was purified from inclusion bodies and refolded in vitro as describe”
MethodActivation of NK Cells and T Cells by NKG2D, a Receptor for Stress-Inducible MICA
Bauer, S., Groh, V., Wu, J., Steinle, A., Phillips, J. H., Lanier, L. L., & Spies, T. (1999) · Science · doi:10.1126/science.285.5428.727 · Cited by 2,999 · cited 1×
“The MHC-encoded proteins MICA and the closely related MICB are distantly related to MHC class I protein”
BackgroundBiology of Natural Killer Cells
Trinchieri, G. (1989) · Advances in Immunology · doi:10.1016/s0065-2776(08)60664-1 · Cited by 2,902 · cited 2×
“(a) Stably transfected CHO cells expressing high levels of NKG2D-DAP10 (filled histograms), NKG2A-CD94 (2) or NKG2C-CD94 (3) as well as untransfected control cells (1) were stained with the absorbed antiserum against mNKG2D.”
MethodIn search of the ‘missing self’: MHC molecules and NK cell recognition
Ljunggren, H.-G., & Kärre, K. (1990) · Immunology Today · doi:10.1016/0167-5699(90)90097-s · Cited by 2,687 · cited 4×
“(a) Stably transfected CHO cells expressing high levels of NKG2D-DAP10 (filled histograms), NKG2A-CD94 (2) or NKG2C-CD94 (3) as well as untransfected control cells (1) were stained with the absorbed antiserum against mNKG2D.”
MethodInfluentialProduction of high-titer helper-free retroviruses by transient transfection.
Pear, W. S., Nolan, G. P., Scott, M. L., & Baltimore, D. (1993) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.90.18.8392 · Cited by 2,266
Lanier, L. L. (1998) · Annual Review of Immunology · doi:10.1146/annurev.immunol.16.1.359 · Cited by 1,648 · cited 4×
“(a) Stably transfected CHO cells expressing high levels of NKG2D-DAP10 (filled histograms), NKG2A-CD94 (2) or NKG2C-CD94 (3) as well as untransfected control cells (1) were stained with the absorbed antiserum against mNKG2D.”
MethodInfluentialAn Activating Immunoreceptor Complex Formed by NKG2D and DAP10
Wu, J., Song, Y., Bakker, A. B. H., Bauer, S., Spies, T., Lanier, L. L., & Phillips, J. H. (1999) · Science · doi:10.1126/science.285.5428.730 · Cited by 1,039 · cited 1×
“Recent evidence indicates that human NKG2D forms a homodimer that associates with the signaling subunit DAP10 on the surface of NK cells and CD8 + T cell”
BackgroundBroad tumor-associated expression and recognition by tumor-derived γδ T cells of MICA and MICB
Groh, V., Rhinehart, R., Secrist, H., Bauer, S., Grabstein, K. H., & Spies, T. (1999) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.96.12.6879 · Cited by 1,028
Groh, V, Bahram, S., Bauer, S., Herman, A., Beauchamp, M., & Spies, T. (1996) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.93.22.12445 · Cited by 1,017 · cited 1×
“MICA and MICB are normally expressed on a subset of intestinal epithelial cells, but their expression is up-regulated by cellular stres”
Background
Research works printed but not linked: 2
- Cosman, D. et al. The human cytomegalovirus (HCMV) glycoprotein, UL16, binds to the MHC class I-related protein, MICB/PERB11, and to two novel, MHC class I-related molecules, ULBP1 and ULBP2. FASEB J. 14, A1018 (2000).
- Chalupny, J. et al. Soluble forms of the novel MHC class I–related molecules, ULBP1 and ULBP2, bind to, and functionally activate NK cells. FASEB J. 14, A1018 (2000).
Cited by
The Three Es of Cancer Immunoediting
Dunn, G. P., Old, L. J., & Schreiber, R. D. (2004) · Annual Review of Immunology · doi:10.1146/annurev.immunol.22.012703.104803 · Cited by 3,072
The Immunobiology of Cancer Immunosurveillance and Immunoediting
Dunn, G. P., Old, L. J., & Schreiber, R. D. (2004) · Immunity · doi:10.1016/j.immuni.2004.07.017 · Cited by 3,032
Lanier, L. L. (2005) · Annual Review of Immunology · doi:10.1146/annurev.immunol.23.021704.115526 · Cited by 2,769
Roles of the immune system in cancer: From tumor initiation to metastatic progression
Gonzalez, H., Hagerling, C., & Werb, Z. (2018) · Genes & Development · doi:10.1101/gad.314617.118 · Cited by 2,111
“Besides NKG2D, NK cells have a repertoire of different stimulatory cell surface receptors, which, upon binding to their tumor-derived ligands, activate NK cells (Cerwenka et al. 2000; Diefenbach et al. 2000, 2001; Raulet 2003).”
BackgroundDecoding the Patterns of Self and Nonself by the Innate Immune System
Medzhitov, R., & Janeway, C. A. (2002) · Science · doi:10.1126/science.1068883 · Cited by 2,154
Activating Receptors and Coreceptors Involved in Human Natural Killer Cell-Mediated Cytolysis
Moretta, A., Bottino, C., Vitale, M., Pende, D., Cantoni, C., Mingari, M. C., Biassoni, R., & Moretta, L. (2001) · Annual Review of Immunology · doi:10.1146/annurev.immunol.19.1.197 · Cited by 1,778
Roles of the NKG2D immunoreceptor and its ligands
Raulet, D. H. (2003) · Nature Reviews Immunology · doi:10.1038/nri1199 · Cited by 1,348
Self-citationThe DNA damage pathway regulates innate immune system ligands of the NKG2D receptor
Gasser, S., Orsulic, S., Brown, E. J., & Raulet, D. H. (2005) · Nature · doi:10.1038/nature03884 · Cited by 1,308
Self-citationCosman, D., Müllberg, J., Sutherland, C. L., Chin, W., Armitage, R., Fanslow, W., Kubin, M., & Chalupny, N. J. (2001) · Immunity · doi:10.1016/s1074-7613(01)00095-4 · Cited by 1,232
Natural Killer Cells: Development, Maturation, and Clinical Utilization
Abel, A. M., Yang, C., Thakar, M. S., & Malarkannan, S. (2018) · Frontiers in Immunology · doi:10.3389/fimmu.2018.01869 · Cited by 1,150
Rae1 and H60 ligands of the NKG2D receptor stimulate tumour immunity
Diefenbach, A., Jensen, E. R., Jamieson, A. M., & Raulet, D. H. (2001) · Nature · doi:10.1038/35093109 · Cited by 1,083
Self-citationInhibiting Stat3 signaling in the hematopoietic system elicits multicomponent antitumor immunity
Kortylewski, M., Kujawski, M., Wang, T., Wei, S., Zhang, S., Pilon-Thomas, S., Niu, G., Kay, H., Mulé, J., Kerr, W. G., et al. (2005) · Nature Medicine · doi:10.1038/nm1325 · Cited by 1,031
Regulation of Cutaneous Malignancy by γδ T Cells
Girardi, M., Oppenheim, D. E., Steele, C. R., Lewis, J. M., Glusac, E., Filler, R., Hobby, P., Sutton, B., Tigelaar, R. E., & Hayday, A. C. (2001) · Science · doi:10.1126/science.1063916 · Cited by 1,004
Liver: An organ with predominant innate immunity
Gao, B., Jeong, W.-I., & Tian, Z. (2008) · Hepatology · doi:10.1002/hep.22034 · Cited by 952
Ghiringhelli, F., Ménard, C., Terme, M., Flament, C., Taieb, J., Chaput, N., Puig, P. E., Novault, S., Escudier, B., Vivier, E., et al. (2005) · The Journal of Experimental Medicine · doi:10.1084/jem.20051511 · Cited by 949
“B16Rae is a melanoma cell line stably transfected with a cDNA encoding Rae (45) that has been provided by D. Raulet (University of California, Berkeley, Berkeley, CA).”
InfluentialCostimulation of CD8αβ T cells by NKG2D via engagement by MIC induced on virus-infected cells
Groh, V., Rhinehart, R., Randolph-Habecker, J., Topp, M. S., Riddell, S. R., & Spies, T. (2001) · Nature Immunology · doi:10.1038/85321 · Cited by 951
Natural killer cells, viruses and cancer
Cerwenka, A., & Lanier, L. L. (2001) · Nature Reviews Immunology · doi:10.1038/35095564 · Cited by 875
Smyth, M. J., Dunn, G. P., & Schreiber, R. D. (2006) · Advances in Immunology · doi:10.1016/s0065-2776(06)90001-7 · Cited by 870
Targeting natural killer cells and natural killer T cells in cancer
Vivier, E., Ugolini, S., Blaise, D., Chabannon, C., & Brossay, L. (2012) · Nature Reviews Immunology · doi:10.1038/nri3174 · Cited by 850
Regulation of Ligands for the NKG2D Activating Receptor
Raulet, D. H., Gasser, S., Gowen, B. G., Deng, W., & Jung, H. (2013) · Annual Review of Immunology · doi:10.1146/annurev-immunol-032712-095951 · Cited by 848
“Furthermore, some of the ligands are transmembrane proteins, while others are glycosylphosphatidylinositol (GPI)-linked (2, 7, 30) (Figure 1).”
BackgroundSelf-citationNKG2D-deficient mice are defective in tumor surveillance in models of spontaneous malignancy
Guerra, N., Tan, Y. X., Joncker, N. T., Choy, A., Gallardo, F., Xiong, N., Knoblaugh, S., Cado, D., Greenberg, N. R., & Raulet, D. H. (2008) · Immunity · doi:10.1016/j.immuni.2008.02.016 · Cited by 850
“, 1999), tumor cell lines (Cerwenka et al., 2000; Diefenbach et al., 2000; Pende et al., 2001; Pende et al., 2002), and in some infected cells (Gourzi et al.”
BackgroundInfluentialSelf-citationThe Molecular Mechanism of Natural Killer Cells Function and Its Importance in Cancer Immunotherapy
Paul, S., & Lal, G. (2017) · Frontiers in Immunology · doi:10.3389/fimmu.2017.01124 · Cited by 825
Gumperz, J. E., Miyake, S., Yamamura, T., & Brenner, M. B. (2002) · The Journal of Experimental Medicine · doi:10.1084/jem.20011786 · Cited by 781
New aspects of natural-killer-cell surveillance and therapy of cancer
Smyth, M. J., Hayakawa, Y., Takeda, K., & Yagita, H. (2002) · Nature Reviews Cancer · doi:10.1038/nrc928 · Cited by 752
Does the Immune System See Tumors as Foreign or Self?
Pardoll, D. (2003) · Annual Review of Immunology · doi:10.1146/annurev.immunol.21.120601.141135 · Cited by 753
A fresh look at tumor immunosurveillance and immunotherapy
Smyth, M. J., Godfrey, D. I., & Trapani, J. A. (2001) · Nature Immunology · doi:10.1038/86297 · Cited by 745
TREMs in the immune system and beyond
Colonna, M. (2003) · Nature Reviews Immunology · doi:10.1038/nri1106 · Cited by 701
Activation of NK cell cytotoxicity
Smyth, M. J., Cretney, E., Kelly, J. M., Westwood, J. A., Street, S. E. A., Yagita, H., Takeda, K., Dommelen, S. L. H. V., Degli-Esposti, M. A., & Hayakawa, Y. (2005) · Molecular Immunology · doi:10.1016/j.molimm.2004.07.034 · Cited by 714
NK cells and cancer immunosurveillance
Waldhauer, I., & Steinle, A. (2008) · Oncogene · doi:10.1038/onc.2008.267 · Cited by 682
“…comprise members of the GPI-anchored Rae-1 family of proteins (Rae1a, b, g, d, and e) as well as the transmembranous ligands H60 (Cerwenka et al., 2000; Diefenbach et al., 2000) and murine UL16-binding protein–like transcript 1 (Mult1) (Carayannopoulos et al., 2002a; Diefenbach et al., 2003).”
BackgroundInfluentialThe Role of the NKG2D Immunoreceptor in Immune Cell Activation and Natural Killing
Jamieson, A. M., Diefenbach, A., McMahon, C. W., Xiong, N., Carlyle, J. R., & Raulet, D. H. (2002) · Immunity · doi:10.1016/s1074-7613(02)00333-3 · Cited by 647
“(Bauer et al., 1999; Cerwenka et al., 2000; Diefenbach et al., 2000, 2001).”
Self-citationCutting Edge: Down-Regulation of MICA on Human Tumors by Proteolytic Shedding
Salih, H. R., Rammensee, H.-G., & Steinle, A. (2002) · The Journal of Immunology · doi:10.4049/jimmunol.169.8.4098 · Cited by 643
“In the mouse, which lacks MHC class I chain (MIC) genes, a family of proteins structurally related to ULBP, the retinoic acidearly (RAE-1) molecules function as ligands for NKG2D (13, 14).”
BackgroundCerwenka, A., Baron, J. L., & Lanier, L. L. (2001) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.201238598 · Cited by 606
NKG2D Receptor and Its Ligands in Host Defense
Lanier, L. L. (2015) · Cancer Immunology Research · doi:10.1158/2326-6066.cir-15-0098 · Cited by 599
Roles of natural killer cells in immunity to cancer, and applications to immunotherapy
Wolf, N. K., Kissiov, D. U., & Raulet, D. H. (2023) · Nature Reviews Immunology · doi:10.1038/s41577-022-00732-1 · Cited by 577
Self-citationImmune functions encoded by the natural killer gene complex
Yokoyama, W. M., & Plougastel, B. F. M. (2003) · Nature Reviews Immunology · doi:10.1038/nri1055 · Cited by 565
Lethal influenza infection in the absence of the natural killer cell receptor gene Ncr1
Gazit, R., Gruda, R., Elboim, M., Arnon, T. I., Katz, G., Achdout, H., Hanna, J., Qimron, U., Landau, G., Greenbaum, E., et al. (2006) · Nature Immunology · doi:10.1038/ni1322 · Cited by 549
Functional expression and release of ligands for the activating immunoreceptor NKG2D in leukemia
Salih, H. R., Antropius, H., Gieseke, F., Lutz, S. Z., Kanz, L., Rammensee, H.-G., & Steinle, A. (2003) · Blood · doi:10.1182/blood-2003-01-0019 · Cited by 541
Regulation of immune cell function and differentiation by the NKG2D receptor
Zafirova, B., Wensveen, F. M., Gulin, M., & Polić, B. (2011) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-011-0797-0 · Cited by 538
“In mice, it binds to the family of retinoic acid early inducible proteins (Rae1) [34, 35].”
Regulation of the Natural Killer Cell Receptor Repertoire
Raulet, D. H., Vance, R. E., & McMahon, C. W. (2001) · Annual Review of Immunology · doi:10.1146/annurev.immunol.19.1.291 · Cited by 521
Self-citationAdjuvant Immunotherapy With Autologous Cytokine-Induced Killer Cells for Hepatocellular Carcinoma
Lee, J. H., Lee, J.-H., Lim, Y.-S., Yeon, J. E., Song, T.-J., Yu, S. J., Gwak, G.-Y., Kim, K. M., Kim, Y. J., Lee, J. W., et al. (2015) · Gastroenterology · doi:10.1053/j.gastro.2015.02.055 · Cited by 503
Pende, D., Rivera, P., Marcenaro, S., Chang, C., Biassoni, R., Conte, R., Kubin, M. Z., Cosman, D. J., Ferrone, S., Moretta, L., et al. (2002) · PubMed · Cited by 593
Intraepithelial lymphocytes: exploring the Third Way in immunology
Hayday, A., Theodoridis, E., Ramsburg, E., & Shires, J. (2001) · Nature Immunology · doi:10.1038/ni1101-997 · Cited by 491
Effect of NKG2D ligand expression on host immune responses
Champsaur, M., & Lanier, L. L. (2010) · Immunological Reviews · doi:10.1111/j.0105-2896.2010.00893.x · Cited by 488
“Prior studies have established that expression of NKG2D ligands on tumors renders them susceptible to killing by NK cells in vitro (16, 23, 24) and results in the in vivo rejection of transplantable tumors expressing these ligands (68, 69).”
BackgroundMethodOppenheim, D. E., Roberts, S. J., Clarke, S. L., Filler, R., Lewis, J. M., Tigelaar, R. E., Girardi, M., & Hayday, A. C. (2005) · Nature Immunology · doi:10.1038/ni1239 · Cited by 454
Diefenbach, A., Tomasello, E., Lucas, M., Jamieson, A. M., Hsia, J. K., Vivier, E., & Raulet, D. H. (2002) · Nature Immunology · doi:10.1038/ni858 · Cited by 452
Self-citationHsu, K. C., Chida, S., Geraghty, D. E., & Dupont, B. (2002) · Immunological Reviews · doi:10.1034/j.1600-065x.2002.19004.x · Cited by 443
Natural Killer Cells and Cancer
(2003) · Advances in Cancer Research · doi:10.1016/s0065-230x(03)90004-2 · Cited by 438
NKG2D recruits two distinct adapters to trigger NK cell activation and costimulation
Gilfillan, S., Ho, E. L., Cella, M., Yokoyama, W. M., & Colonna, M. (2002) · Nature Immunology · doi:10.1038/ni857 · Cited by 437
Autoreactivity by design: innate B and T lymphocytes
Bendelac, A., Bonneville, M., & Kearney, J. F. (2001) · Nature Reviews Immunology · doi:10.1038/35105052 · Cited by 416
Iannello, A., Thompson, T. W., Ardolino, M., Lowe, S. W., & Raulet, D. H. (2013) · Journal of Experimental Medicine · doi:10.1084/jem.20130783 · Cited by 414
“…from our labora tory demonstrated that transplanted tumor cells expressing NKG2D ligands are rejected by NK cells and, in some cases, T cells (Diefenbach et al., 2000, 2001, 2003), and that knock out mice lacking NKG2D display an enhanced incidence and/or more rapid onset of cancers in…”
Self-citationInterplay of natural killer cells and their receptors with the adaptive immune response
Raulet, D. H. (2004) · Nature Immunology · doi:10.1038/ni1114 · Cited by 413
Self-citationNKG2D ligands in tumor immunity
Nausch, N., & Cerwenka, A. (2008) · Oncogene · doi:10.1038/onc.2008.272 · Cited by 408
“…cells activated by antigen-presenting cells, or T-cell blasts stimulated with super antigen, anti-CD3/anti-CD28 in combination with PMA, or infected with HIV, upregulate NKG2D ligands (Diefenbach et al., 2000; Molinero et al., 2002; Rabinovich et al., 2003; Cerboni et al., 2007; Ward et al., 2007).”
InfluentialOncogenic stress sensed by the immune system: role of natural killer cell receptors
Raulet, D. H., & Guerra, N. (2009) · Nature Reviews Immunology · doi:10.1038/nri2604 · Cited by 404
Self-citationKmiecik, J., Poli, A., Brons, N. H. C., Waha, A., Eide, G. E., Enger, P. Ø., Zimmer, J., & Chekenya, M. (2013) · Journal of Neuroimmunology · doi:10.1016/j.jneuroim.2013.08.013 · Cited by 389
“human APCs so far, while in rodents it is believed that NKG2D expression on activated macrophages plays an important role in immunity (Diefenbach et al., 2000).”
Interferon-producing killer dendritic cells provide a link between innate and adaptive immunity
Chan, C. W., Crafton, E., Fan, H.-N., Flook, J., Yoshimura, K., Skarica, M., Brockstedt, D., Dubensky, T. W., Stins, M. F., Lanier, L. L., et al. (2006) · Nature Medicine · doi:10.1038/nm1352 · Cited by 399
Recognition of Tumors by the Innate Immune System and Natural Killer Cells
Marcus, A., Gowen, B. G., Thompson, T. W., Iannello, A., Ardolino, M., Deng, W., Wang, L., Shifrin, N., & Raulet, D. H. (2014) · Advances in Immunology · doi:10.1016/b978-0-12-800267-4.00003-1 · Cited by 394
“First, cellular proliferation is not sufficient for ligand induction in all cell types, such as activated mouse T cells (Diefenbach et al., 2000), possibly due to a specific genetic repression of the ligand genes; this would ensure that those cells are not inadvertently destroyed .”
InfluentialSelf-citationOlson, J. A., Leveson-Gower, D. B., Gill, S., Baker, J., Beilhack, A., & Negrin, R. S. (2010) · Blood · doi:10.1182/blood-2009-05-222190 · Cited by 384
Role of NKG2D signaling in the cytotoxicity of activated and expanded CD8+ T cells
Verneris, M. R., Karami, M., Baker, J., Jayaswal, A., & Negrin, R. S. (2004) · Blood · doi:10.1182/blood-2003-06-2125 · Cited by 383
NKG2D-DAP10 triggers human NK cell–mediated killing via a Syk-independent regulatory pathway
Billadeau, D. D., Upshaw, J. L., Schoon, R. A., Dick, C. J., & Leibson, P. J. (2003) · Nature Immunology · doi:10.1038/ni929 · Cited by 374
Promiscuity and the single receptor: NKG2D
Eagle, R. A., & Trowsdale, J. (2007) · Nature Reviews Immunology · doi:10.1038/nri2144 · Cited by 374
Gilfillan, S., Chan, C. J., Cella, M., Haynes, N. M., Rapaport, A. S., Boles, K. S., Andrews, D. M., Smyth, M. J., & Colonna, M. (2008) · The Journal of Experimental Medicine · doi:10.1084/jem.20081752 · Cited by 361
Armeanu, S., Bitzer, M., Lauer, U. M., Venturelli, S., Pathil, A., Krusch, M., Kaiser, S., Jobst, J., Smirnow, I., Wagner, A., et al. (2005) · Cancer Research · doi:10.1158/0008-5472.can-04-4252 · Cited by 358
“This has been shown in mice, where a family of proteins structurally related to ULBP, the retinoic acid early inducible (RAE-1) molecules function as ligands for NKG2D (40, 41).”
Induction of tumor-specific T cell memory by NK cell–mediated tumor rejection
Kelly, J. M., Darcy, P. K., Markby, J. L., Godfrey, D. I., Takeda, K., Yagita, H., & Smyth, M. J. (2002) · Nature Immunology · doi:10.1038/ni746 · Cited by 356
On guard—activating NK cell receptors
Lanier, L. L. (2001) · Nature Immunology · doi:10.1038/83130 · Cited by 346
NKG2D function protects the host from tumor initiation
Smyth, M. J., Swann, J., Cretney, E., Zerafa, N., Yokoyama, W. M., & Hayakawa, Y. (2005) · The Journal of Experimental Medicine · doi:10.1084/jem.20050994 · Cited by 342
“Although MIC molecules have not been found in mice, the retinoic acid early inducible-1 ( Rae-1 ) gene products UL16binding protein-like transcript 1 (Mult1) and a distantly related minor histocompatibility Ag, H60, have been reported as NKG2D ligands in mice (5, 6, 8, 9).”
BackgroundNatarajan, K., Dimasi, N., Wang, J., Mariuzza, R. A., & Margulies, D. H. (2002) · Annual Review of Immunology · doi:10.1146/annurev.immunol.20.100301.064812 · Cited by 335
Pende, D., Cantoni, C., Rivera, P., Vitale, M., Castriconi, R., Marcenaro, S., Nanni, M., Biassoni, R., Bottino, C., Moretta, A., et al. (2001) · European Journal of Immunology · doi:10.1002/1521-4141(200104)31:4<1076::aid-immu1076>3.0.co;2-y · Cited by 334
Niyonsaba, F., Someya, A., Hirata, M., Ogawa, H., & Nagaoka, I. (2001) · European Journal of Immunology · doi:10.1002/1521-4141(200104)31:4<1066::aid-immu1066>3.0.co;2-# · Cited by 347
Wu, J. D., Higgins, L. M., Steinle, A., Cosman, D., Haugk, K., & Plymate, S. R. (2004) · Journal of Clinical Investigation · doi:10.1172/jci200422206 · Cited by 330
Evasion from NK Cell Immunity by MHC Class I Chain-Related Molecules Expressing Colon Adenocarcinoma
Doubrovina, E. S., Doubrovin, M. M., Vider, E., Sisson, R. B., O’Reilly, R. J., Dupont, B., & Vyas, Y. M. (2003) · The Journal of Immunology · doi:10.4049/jimmunol.171.12.6891 · Cited by 324
Human microRNAs regulate stress-induced immune responses mediated by the receptor NKG2D
Stern-Ginossar, N., Gur, C., Biton, M., Horwitz, E., Elboim, M., Stanietsky, N., Mandelboim, M., & Mandelboim, O. (2008) · Nature Immunology · doi:10.1038/ni.1642 · Cited by 315
Lang, P. A., Lang, K. S., Xu, H. C., Grusdat, M., Parish, I. A., Recher, M., Elford, A. R., Dhanji, S., Shaabani, N., Tran, C. W., et al. (2012) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1118834109 · Cited by 311
Self-citationAzumi, K., De Santis, R., De Tomaso, A., Rigoutsos, I., Yoshizaki, F., Pinto, M. R., Marino, R., Shida, K., Ikeda, M., Ikeda, M., et al. (2003) · Immunogenetics · doi:10.1007/s00251-003-0606-5 · Cited by 302
“In contrast, the majority of ligands for these receptors in the vertebrates are either MHC or MHC related molecules, either by sequence, or potentially, structure (Arase et al. 2002; Diefenbach et al. 2000).”
BackgroundNKG2D Blockade Prevents Autoimmune Diabetes in NOD Mice
Ogasawara, K., Hamerman, J. A., Ehrlich, L. R., Bour-Jordan, H., Santamaria, P., Bluestone, J. A., & Lanier, L. L. (2004) · Immunity · doi:10.1016/j.immuni.2004.05.008 · Cited by 302
Andoniou, C. E., van Dommelen, S. L. H., Voigt, V., Andrews, D. M., Brizard, G., Asselin-Paturel, C., Delale, T., Stacey, K. J., Trinchieri, G., & Degli-Esposti, M. A. (2005) · Nature Immunology · doi:10.1038/ni1244 · Cited by 285
Dunn, C., Chalupny, N. J., Sutherland, C. L., Dosch, S., Sivakumar, P. V., Johnson, D. C., & Cosman, D. (2003) · The Journal of Experimental Medicine · doi:10.1084/jem.20022059 · Cited by 280
“There are no known mouse equivalents to the MIC genes, but several mouse ligands for NKG2D have been described (18, 19, 32).”
BackgroundSutherland, C. L., Chalupny, N. J., Schooley, K., VandenBos, T., Kubin, M., & Cosman, D. (2002) · The Journal of Immunology · doi:10.4049/jimmunol.168.2.671 · Cited by 276
Lodoen, M., Ogasawara, K., Hamerman, J. A., Arase, H., Houchins, J. P., Mocarski, E. S., & Lanier, L. L. (2003) · The Journal of Experimental Medicine · doi:10.1084/jem.20021973 · Cited by 275
“The products of at least six different genes have been identified as ligands for mouse NKG2D: RAE-1 , RAE1 , RAE-1 , RAE-1 , RAE-1 , and H-60 (17, 18).”
BackgroundCarayannopoulos, L. N., Naidenko, O. V., Fremont, D. H., & Yokoyama, W. M. (2002) · The Journal of Immunology · doi:10.4049/jimmunol.169.8.4079 · Cited by 274
“The analogy between human and murine systems being accordingly unsatisfying, we suspected the existence of NKG2D-binding proteins that had eluded detection by the expression cloning systems previously used, both of which were based on transformed cell cDNA libraries (1, 13).”
BackgroundBorrego, F., Kabat, J., Kim, D.-K., Lieto, L., Maasho, K., Peña, J., Solana, R., & Coligan, J. E. (2002) · Molecular Immunology · doi:10.1016/s0161-5890(01)00107-9 · Cited by 271
Natural killer cells and viral infections
French, A. R., & Yokoyama, W. M. (2003) · Current Opinion in Immunology · doi:10.1016/s095279150200002x · Cited by 269
NK cells mediate clearance of CD8 + T cell–resistant tumors in response to STING agonists
Nicolai, C. J., Wolf, N., Chang, I.-C., Kirn, G., Marcus, A., Ndubaku, C. O., McWhirter, S. M., & Raulet, D. H. (2020) · Science Immunology · doi:10.1126/sciimmunol.aaz2738 · Cited by 268
Self-citationLilue, J., Doran, A. G., Fiddes, I. T., Abrudan, M., Armstrong, J., Bennett, R., Chow, W., Collins, J., Collins, S., Czechanski, A., et al. (2018) · Nature Genetics · doi:10.1038/s41588-018-0223-8 · Cited by 267
Strid, J., Roberts, S. J., Filler, R. B., Lewis, J. M., Kwong, B. Y., Schpero, W., Kaplan, D. H., Hayday, A. C., & Girardi, M. (2008) · Nature Immunology · doi:10.1038/ni1556 · Cited by 266
Licensing of natural killer cells by self‐major histocompatibility complex class I
Yokoyama, W. M., & Kim, S. (2006) · Immunological Reviews · doi:10.1111/j.1600-065x.2006.00458.x · Cited by 259
“Groh V, Rhinehart R, Randolph-Habecker J, Topp MS, Riddell SR, Spies T. Costimulation of CD8ab T cells by NKG2D via engagement by MIC induced on virus-infected cells.”
BackgroundInfluentialSkov, S., Pedersen, M. T., Andresen, L., Thor Straten, P., Woetmann, A., & Ødum, N. (2005) · Cancer Research · doi:10.1158/0008-5472.can-05-0599 · Cited by 259
Jinushi, M., Vanneman, M., Munshi, N. C., Tai, Y.-T., Prabhala, R. H., Ritz, J., Neuberg, D., Anderson, K. C., Carrasco, D. R., & Dranoff, G. (2008) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0711293105 · Cited by 256
Uterine Natural Killer Cells: Functional Distinctions and Influence on Pregnancy in Humans and Mice
Gaynor, L. M., & Colucci, F. (2017) · Frontiers in Immunology · doi:10.3389/fimmu.2017.00467 · Cited by 250
Pathogenesis of murine cytomegalovirus infection
Krmpotic, A., Bubic, I., Polic, B., Lucin, P., & Jonjic, S. (2003) · Microbes and Infection · doi:10.1016/j.micinf.2003.09.007 · Cited by 247
“NKG2D is expressed not only on NK cells but also on activated macrophages and T lymphocytes, where it serves as a co-activating receptor [91,94,95].”
BackgroundChen, S., Zhu, H., & Jounaidi, Y. (2024) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-024-02005-w · Cited by 234
“…of an activation domain in its cytoplasmic tail, NKG2D associates with adapter DAP10 227 after binding to ligand UL16-binding proteins (ULBP) 1 – 6 228 and to ligands MICA and MICB, 69 whose expression is regulated by the heat shock stress pathway 229 or by DNA damage induced by chemotherapy and…”
BackgroundJinushi, M., Takehara, T., Tatsumi, T., Kanto, T., Groh, V., Spies, T., Kimura, R., Miyagi, T., Mochizuki, K., Sasaki, Y., et al. (2003) · International Journal of Cancer · doi:10.1002/ijc.10966 · Cited by 244
In Vivo Survival and Homeostatic Proliferation of Natural Killer Cells
Prlic, M., Blazar, B. R., Farrar, M. A., & Jameson, S. C. (2003) · The Journal of Experimental Medicine · doi:10.1084/jem.20021847 · Cited by 243
NKG2D ligands: key targets of the immune response
González, S., López-Soto, A., Suarez-Alvarez, B., López-Vázquez, A., & López-Larrea, C. (2008) · Trends in Immunology · doi:10.1016/j.it.2008.04.007 · Cited by 241
Systemic NKG2D Down-Regulation Impairs NK and CD8 T Cell Responses In Vivo
Wiemann, K., Mittrücker, H.-W., Feger, U., Welte, S. A., Yokoyama, W. M., Spies, T., Rammensee, H.-G., & Steinle, A. (2005) · The Journal of Immunology · doi:10.4049/jimmunol.175.2.720 · Cited by 240
NKG2D and its ligands in cancer
Dhar, P., & Wu, J. D. (2018) · Current Opinion in Immunology · doi:10.1016/j.coi.2018.02.004 · Cited by 239
Tieng, V., Le Bouguénec, C., du Merle, L., Bertheau, P., Desreumaux, P., Janin, A., Charron, D., & Toubert, A. (2002) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.032668099 · Cited by 235
Viral modulation of NK cell immunity
Lodoen, M. B., & Lanier, L. L. (2005) · Nature Reviews Microbiology · doi:10.1038/nrmicro1066 · Cited by 234
Activation and self‐tolerance of natural killer cells
Gasser, S., & Raulet, D. H. (2006) · Immunological Reviews · doi:10.1111/j.1600-065x.2006.00460.x · Cited by 233
“NKG2D is expressed on virtually all NK cells and is usually called an NK receptor (42, 44, 46, 56).”
BackgroundSelf-citationDC-NK cell cross talk as a novel CD4+ T-cell–independent pathway for antitumor CTL induction
Adam, C., King, S., Allgeier, T., Braumüller, H., Lüking, C., Mysliwietz, J., Kriegeskorte, A., Busch, D. H., Röcken, M., & Mocikat, R. (2005) · Blood · doi:10.1182/blood-2004-09-3775 · Cited by 233
The innate immune response to tumors and its role in the induction of T‐cell immunity
Diefenbach, A., & Raulet, D. H. (2002) · Immunological Reviews · doi:10.1034/j.1600-065x.2002.18802.x · Cited by 228
Self-citation
Metadata
- Authors
- Diefenbach, A., Jamieson, A. M., Liu, S. D., Shastri, N., & Raulet, D. H.
- Affiliations
- University of California, Berkeley (US)
- Corresponding author
- Raulet, David H.
- Venue
- Nature Immunology
- Published
- 2000-08
- Volume
- 1
- Issue
- 2
- Pages
- 119-126
- ISSN
- 1529-2908 (ISSN-L)
- 1529-2916
- OpenAlex
- W1603913234
- Cited by
- 878
- References
- 41
- Citations by year
- 2026: 9 · 2025: 4 · 2024: 17 · 2023: 12 · 2022: 28 · 2021: 17 · 2020: 23 · 2019: 18 · 2018: 29 · 2017: 31 · 2016: 17 · 2015: 23 · 2014: 24 · 2013: 28 · 2012: 38
- FWCI
- 18.39
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.springer.com/tdm (tdm)
- Locations
- Nature Immunology (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Life Sciences › Immunology and Microbiology › Immunology › Immune Cell Function and Interaction
- Life Sciences › Immunology and Microbiology › Immunology › interferon and immune responses
- Life Sciences › Immunology and Microbiology › Immunology › Immunotherapy and Immune Responses
- Keywords
- NKG2D, NKG2D ligands, natural killer cells, macrophages, cancer cells, innate immunity, NK cell cytotoxicity, interferon-gamma, nitric oxide, TNF-α, MHC class I-related molecules, CD8+ T cells, expression cloning
- MeSH terms
- Animals, Chlorocebus aethiops, Cloning, Molecular, Cricetinae, Humans, Killer Cells, Natural, Ligands, Lymphocyte Activation, Macrophage Activation, Membrane Proteins, Mice, Inbred BALB C, Mice, Inbred C57BL, Receptors, Immunologic, Tumor Cells, Cultured, Minor Histocompatibility Antigens, CHO Cells, Macrophages, Peritoneal, COS Cells, Mice, Receptors, Natural Killer Cell, NK Cell Lectin-Like Receptor Subfamily K
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.